Drug Shortage Report for IMIPENEM AND CILASTATIN FOR INJECTION

Last updated on 2018-08-15 History
Report ID 2148
Drug Identification Number 02357437
Brand name IMIPENEM AND CILASTATIN FOR INJECTION
Common or Proper name Imipenem and Cilastatin
Company Name PFIZER CANADA ULC
Active Ingredient(s) CILASTATIN IMIPENEM
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 500mg x 10
ATC code J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2016-04-02
Estimated end date
Actual end date 2018-08-14
Shortage status Resolved
Updated date 2018-08-15
Company comments The drug has been discontinued.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-08-15 English Compare
v4 2018-08-14 French Compare
v3 2018-08-14 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare